Actemra
A return to ‘pre-pandemic levels’
Shortages of intravenous and subcutaneous Actemra have been resolved as pharmacists thanked for their patience A shortage of Actemra (tocilizumab) has finally been resolved after supply was battered following recommendations …
Shortage continues
TGA warns of continuing shortages of an arthritis treatment, but says the situation may be easing The Therapeutic Goods Administration (TGA) says there may be some light at the end …
Pharmacist substitution extended
Supply is improving for tocilizumab (Actemra) products but disruptions to some products will continue beyond this month, warns Roche Availability of tocilizumab (Actemra) products is “improving” and supply should be …
Shortage woes
Wholesaler portals will likely show zero stock quantity for both Actemra ACTPen autoinjector and pre-filled syringe, even if they are available, said TGA The TGA has provided pharmacists with instructions …
Substitute cost disadvantage ‘unjust’
Pharmacy body raises concerns that Actemra substitution issues will impact affordability and equity of access The PSA has raised concerns about the news that community pharmacists are now able to …
Scarcity drives pharmacy substitution
Community pharmacists are now able to substitute Actemra formulations without prior prescriber approval, due to serious shortages Two tocilizumab (Actemra) formulations are now effectively interchangeable at the pharmacy level after …
Struggling for supply
Shortage notice issued for multiple presentations of arthritis treatment The Therapeutic Goods Administration (TGA) has issued a warning regarding shortages of multiple presentations of tocilizumab (Actemra). Roche, the sponsor of …
Arthritis drug shortage looms
TGA working with wholesalers to restrict available Actemra stock to community pharmacies and hospitals as stocks dwindle Australia faces a shortage of arthritis drug Actemra (tocilizumab) following recommendation by the …